CFDE Data Portal | Search EIF3G

	Label	Description
	EIF3G Gene (Entity type)	ENSG00000130811 - eukaryotic translation initiation factor 3 subunit G
	EIF3G associations Collection (Entity type)	Associations for EIF3G_associations
	EIF3G associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE135350 2 V 4 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	EIF3G YEAST Protein (Entity type)	Eukaryotic translation initiation factor 3 subunit G
	GSE216043 10 V 5 CISPLATIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	EIF3G DICDI Protein (Entity type)	Eukaryotic translation initiation factor 3 subunit G
	GSE120612 4 V 1 ETOPOSIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	EIF3G DANRE Protein (Entity type)	Eukaryotic translation initiation factor 3 subunit G

EIF3G

ENSG00000130811 - eukaryotic translation initiation factor 3 subunit G

EIF3G associations

Associations for EIF3G_associations

EIF3G associations.tsv

A file from IDG as part of the Harmonizome project

GSE135350 2 V 4 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE120612 etoposide leukocyte 6 v 1 human up

A Gene Set from LINCS

EIF3G YEAST

Eukaryotic translation initiation factor 3 subunit G

GSE216043 10 V 5 CISPLATIN HUMAN UP

A Gene Set from LINCS

EIF3G DICDI

Eukaryotic translation initiation factor 3 subunit G

GSE120612 4 V 1 ETOPOSIDE HUMAN UP

A Gene Set from LINCS

EIF3G DANRE

Eukaryotic translation initiation factor 3 subunit G

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.